NCT00268385 2026-03-19Vorinostat and Temozolomide in Treating Patients With Malignant GliomasNational Cancer Institute (NCI)Phase 1 Active not recruiting83 enrolled
NCT02192359 2025-11-14Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasCity of Hope Medical CenterPhase 1 Active not recruiting18 enrolled 16 charts